GNA11 and cancer: Of 87 patients, 21 patients were analyzed using TruSeq Amplicom 48 Gene Cancer Panel with the MiSeq system for GNAQ and GNA11 mutations, while the rest were analyzed using 592 genes panel with the NexrSeq instrument for NGS assay.